Grond S, Jage J, Van Aken H
Klinik für Anästhesiologie und Operative Intensivmedizin, Klinikum Lippe-Detmold, Röntgenstrasse 18, 32756, Detmold, Deutschland.
Anaesthesist. 2008 Jul;57(7):704-10. doi: 10.1007/s00101-008-1369-z.
Intravenous patient-controlled analgesia (i.v. PCA) for parenteral postoperative pain control is considered standard therapy as patients can individually titrate the amount of analgesic as needed. Iontophoretic patient-activated transdermal systems (IPATS) are a new non-invasive pre-programmed method for postoperative pain control. By pressing the dosing button a 40 microg dose of fentanyl is delivered over a 10 min period via iontophoresis through the intact skin. Several comparative randomized controlled trials have demonstrated that IPATS provide postoperative pain control equivalent to i.v. PCA with morphine. Thus, IPATS is a new method in the management of acute postoperative pain which increases patient mobility and reduces time and effort of care as well as the risk of programming errors. In this review the efficacy, pharmacokinetics, handling and process cost-effectiveness of IPATS are discussed.
静脉自控镇痛(i.v. PCA)用于术后肠外疼痛控制被视为标准疗法,因为患者可根据需要自行调整镇痛药剂量。离子电渗透患者激活型经皮给药系统(IPATS)是一种用于术后疼痛控制的新型非侵入性预编程方法。通过按下给药按钮,40微克剂量的芬太尼会在10分钟内通过离子电渗透经完整皮肤给药。多项比较性随机对照试验表明,IPATS提供的术后疼痛控制效果与静脉注射吗啡PCA相当。因此,IPATS是急性术后疼痛管理中的一种新方法,它可提高患者的活动能力,减少护理时间和工作量以及编程错误风险。本文综述讨论了IPATS的疗效、药代动力学、操作及过程成本效益。